Literature DB >> 33499343

Risk of Amyotrophic Lateral Sclerosis and Exposure to Particulate Matter from Vehicular Traffic: A Case-Control Study.

Tommaso Filippini1, Jessica Mandrioli2, Carlotta Malagoli1, Sofia Costanzini3, Andrea Cherubini4, Giuseppe Maffeis4, Marco Vinceti1,5.   

Abstract

(1) Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with still unknown etiology. Some occupational and environmental risk factors have been suggested, including long-term air pollutant exposure. We carried out a pilot case-control study in order to evaluate ALS risk due to particulate matter with a diameter of ≤10 µm (PM10) as a proxy of vehicular traffic exposure. (2)
Methods: We recruited ALS patients and controls referred to the Modena Neurology ALS Care Center between 1994 and 2015. Using a geographical information system, we modeled PM10 concentrations due to traffic emissions at the geocoded residence address at the date of case diagnosis. We computed the odds ratio (OR) and 95% confidence interval (CI) of ALS according to increasing PM10 exposure, using an unconditional logistic regression model adjusted for age and sex. (3)
Results: For the 132 study participants (52 cases and 80 controls), the average of annual median and maximum PM10 concentrations were 5.2 and 38.6 µg/m3, respectively. Using fixed cutpoints at 5, 10, and 20 of the annual median PM10 levels, and compared with exposure <5 µg/m3, we found no excess ALS risk at 5-10 µg/m3 (OR 0.87, 95% CI 0.39-1.96), 10-20 µg/m3 (0.94, 95% CI 0.24-3.70), and ≥20 µg/m3 (0.87, 95% CI 0.05-15.01). Based on maximum PM10 concentrations, we found a statistically unstable excess ALS risk for subjects exposed at 10-20 µg/m3 (OR 4.27, 95% CI 0.69-26.51) compared with those exposed <10 µg/m3. However, risk decreased at 20-50 µg/m3 (OR 1.49, 95% CI 0.39-5.75) and ≥50 µg/m3 (1.16, 95% CI 0.28-4.82). ALS risk in increasing tertiles of exposure showed a similar null association, while comparison between the highest and the three lowest quartiles lumped together showed little evidence for an excess risk at PM10 concentrations (OR 1.13, 95% CI 0.50-2.55). After restricting the analysis to subjects with stable residence, we found substantially similar results. (4) Conclusions: In this pilot study, we found limited evidence of an increased ALS risk due to long-term exposure at high PM10 concentration, though the high statistical imprecision of the risk estimates, due to the small sample size, particularly in some exposure categories, limited our capacity to detect small increases in risk, and further larger studies are needed to assess this relation.

Entities:  

Keywords:  amyotrophic lateral sclerosis; case-control study; environmental factors; geographical information system; particulate matter; vehicular traffic

Year:  2021        PMID: 33499343      PMCID: PMC7908475          DOI: 10.3390/ijerph18030973

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  58 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Spatial Assessment of the Association between Long-Term Exposure to Environmental Factors and the Occurrence of Amyotrophic Lateral Sclerosis in Catalonia, Spain: A Population-Based Nested Case-Control Study.

Authors:  Mònica Povedano; Marc Saez; Juan-Antonio Martínez-Matos; Maria Antònia Barceló
Journal:  Neuroepidemiology       Date:  2018-05-31       Impact factor: 3.282

Review 3.  Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants.

Authors:  Efthimios Dardiotis; Vasileios Siokas; Maria Sokratous; Zisis Tsouris; Amalia Michalopoulou; Athina Andravizou; Metaxia Dastamani; Styliani Ralli; Marco Vinceti; Aristidis Tsatsakis; Georgios M Hadjigeorgiou
Journal:  Environ Int       Date:  2018-04-17       Impact factor: 9.621

Review 4.  Amyotrophic lateral sclerosis and lead: A systematic update.

Authors:  Cristiano Farace; Grazia Fenu; Simone Lintas; Riccardo Oggiano; Andrea Pisano; Angela Sabalic; Giuliana Solinas; Beatrice Bocca; Giovanni Forte; Roberto Madeddu
Journal:  Neurotoxicology       Date:  2020-09-14       Impact factor: 4.294

5.  Determinants of serum cadmium levels in a Northern Italy community: A cross-sectional study.

Authors:  Tommaso Filippini; Bernhard Michalke; Carlotta Malagoli; Peter Grill; Ilaria Bottecchi; Marcella Malavolti; Luciano Vescovi; Sabina Sieri; Vittorio Krogh; Andrea Cherubini; Giuseppe Maffeis; Marina Modenesi; Paolo Castiglia; Marco Vinceti
Journal:  Environ Res       Date:  2016-06-14       Impact factor: 6.498

6.  Prospective study of occupation and amyotrophic lateral sclerosis mortality.

Authors:  M G Weisskopf; M L McCullough; N Morozova; E E Calle; M J Thun; A Ascherio
Journal:  Am J Epidemiol       Date:  2005-11-03       Impact factor: 4.897

7.  MRI and neuropathological validations of the involvement of air pollutants in cortical selective neuronal loss.

Authors:  Sohail Ejaz; Khaleeq Anwar; Muhammad Ashraf
Journal:  Environ Sci Pollut Res Int       Date:  2014-03       Impact factor: 4.223

Review 8.  Amyotrophic lateral sclerosis and environmental factors.

Authors:  Virginia Bozzoni; Orietta Pansarasa; Luca Diamanti; Guido Nosari; Cristina Cereda; Mauro Ceroni
Journal:  Funct Neurol       Date:  2016 Jan-Mar

9.  Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Authors:  Marco Vinceti; Nikolay Solovyev; Jessica Mandrioli; Catherine M Crespi; Francesca Bonvicini; Elisa Arcolin; Eleni Georgoulopoulou; Bernhard Michalke
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

10.  Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis.

Authors:  Tullia Maraldi; Francesca Beretti; Laura Anselmi; Cinzia Franchin; Giorgio Arrigoni; Luca Braglia; Jessica Mandrioli; Marco Vinceti; Sandra Marmiroli
Journal:  Neurotoxicology       Date:  2019-10-01       Impact factor: 4.294

View more
  4 in total

1.  Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy.

Authors:  Giulia Gianferrari; Ilaria Martinelli; Elisabetta Zucchi; Cecilia Simonini; Nicola Fini; Marco Vinceti; Salvatore Ferro; Annalisa Gessani; Elena Canali; Franco Valzania; Elisabetta Sette; Maura Pugliatti; Valeria Tugnoli; Lucia Zinno; Salvatore Stano; Mario Santangelo; Silvia De Pasqua; Emilio Terlizzi; Donata Guidetti; Doriana Medici; Fabrizio Salvi; Rocco Liguori; Veria Vacchiano; Mario Casmiro; Pietro Querzani; Marco Currò Dossi; Alberto Patuelli; Simonetta Morresi; Marco Longoni; Patrizia De Massis; Rita Rinaldi; Annamaria Borghi; Amedeo Amedei; Jessica Mandrioli
Journal:  Biomedicines       Date:  2022-03-31

2.  PM2.5 composition and disease aggravation in amyotrophic lateral sclerosis: An analysis of long-term exposure to components of fine particulate matter in New York State.

Authors:  Yanelli Nunez; Amelia K Boehme; Jeff Goldsmith; Maggie Li; Aaron van Donkelaar; Marc G Weisskopf; Diane B Re; Randall V Martin; Marianthi-Anna Kioumourtzoglou
Journal:  Environ Epidemiol       Date:  2022-03-30

Review 3.  A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk.

Authors:  Diane B Re; Beizhan Yan; Lilian Calderón-Garcidueñas; Angeline S Andrew; Maeve Tischbein; Elijah W Stommel
Journal:  J Neurol       Date:  2022-01-01       Impact factor: 6.682

4.  Residential exposure to electromagnetic fields and risk of amyotrophic lateral sclerosis: a dose-response meta-analysis.

Authors:  Tommaso Filippini; Elizabeth E Hatch; Marco Vinceti
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.